首页> 外文期刊>Advances in Animal and Veterinary Sciences >Lactic Acid Bacteria as Mucosal Delivery Vaccine
【24h】

Lactic Acid Bacteria as Mucosal Delivery Vaccine

机译:乳酸菌作为粘膜递送疫苗

获取原文
       

摘要

Mucosal surfaces of the body provide a congenial entry portal for all the known and emerging infective pathogenic microbes. Therefore, it is imminent that vaccination strategies need to be evolved for developing vaccines that are capable of hindering the entry of microbes through mucosal surfaces. The present day conventional vaccination strategies, though effective against some pathogens, seems ineffective due to certain drawbacks such as being ineffectual in generating immune response at mucosal surfaces and also of the difficulties experienced during administration of vaccine. Hence, novel strategies, such as development of oralasal mucosal vaccines vectored by probiotic microbes, can be thought of as an alternative as they are effective in inducing protective immunity at the site of infection, capable of eliciting systemic and mucosal immunity and moreover, easy to administer. This review outlines the efficacy of probiotic mucosal vaccines in modulating the immune system, particularly emphasizing on two major lactic acid bacilli as candidates for mucosal vaccine delivery vehicles in livestock and poultry
机译:身体的粘膜表面为所有已知和新出现的感染性病原微生物提供了有利的入口。因此,迫切需要发展疫苗接种策略以开发能够阻碍微生物通过粘膜表面进入的疫苗。当今的常规疫苗接种策略尽管对某些病原体有效,但由于某些缺点如在粘膜表面产生免疫应答的效率低下以及疫苗施用过程中遇到的困难而显得无效。因此,可以将新策略(例如开发由益生菌微生物载体的口服/鼻粘膜疫苗)视为一种替代方案,因为它们可以有效地在感染部位诱导保护性免疫,能够引发全身和粘膜免疫,此外,易于管理。这篇综述概述了益生菌粘膜疫苗在调节免疫系统中的功效,特别强调了两种主要的乳酸杆菌作为牲畜和家禽粘膜疫苗输送工具的候选者

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号